HPS2179-95
77327-45-8
默认>95%HPLC,若需其他规格请洽询
产品编号 | 规格 | 货期 | 销售价 | 折扣价 | 数量 | 操作 |
---|---|---|---|---|---|---|
HPS2179-95 | 默认>95%HPLC,若需其他规格请洽询 |
25天
|
敬请询价 | 敬请询价 |
![]() ![]() |
名字 | (d(CH₂)₅¹,Tyr(Me)²,Orn⁸)-Oxytocin trifluoroacetate salt |
---|---|
序列(三字母) | β-Mercapto-β,β-cyclopentamethylene-propionyl-Tyr(Me)-Ile-Gln-Asn-Cys-Pro-Orn-Gly-NH₂ trifluoroacetate salt(Disulfide bond) |
序列(单字母) | β-Mercapto-β,β-cyclopentamethylene-propionyl-Y(Me)-IQNCP-Orn-G-NH₂(Disulfide bond) |
CAS# | 77327-45-8 |
分子式 | C₄₈H₇₄N₁₂O₁₂S₂ |
分子量 | 1075.32 |
纯度 | 默认>95%HPLC,若需其他规格请洽询 |
合成方法 | Synthetic |
储存条件 | -20 ± 5 °C |
应用 | Pituitary & Hypothalamic Hormones |
描述 | Potent oxytocin antagonist with a pA₂ value of 7.35 ± 0.08. (d(CH₂)₅¹,Tyr(Me)²,Orn⁸)-Vasotocin has been used to support the hypothesis that pituitary secretion of oxytocin is associated with coactivation of centrally projecting brain oxytocin pathways, some of which are causally related to the induced inhibition of food intake. Furthermore, this compound competitively inhibited arginine vasotocin (AVT) contractions without affecting AVT efficacy. |